Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human PDGF Gel in Superficial/Deep II-degree Burns
CTR20221760Phase 2Completed
- Sponsor
- Beijing Huaren Biotechnology
- Start
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of becaplermin in thermal injury, sponsored by Beijing Huaren Biotechnology. Started Jul 2022; status: completed.
02
Drugs
becaplermin
03
Conditions
thermal injury
Beyond the preview
Go deeper on CTR20221760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221760.